China Everbright targets fintech and healthcare

The mainland group's Hong Kong investment arm has been busy raising new funds this year and has outlined the types of assets it is targeting.
Semiconductors: expected to surpass oil in terms of imports into China
Semiconductors: expected to surpass oil in terms of imports into China

China Everbright Limited CEL, the Hong Kong investment arm of mainland financial services group China Everbright, has raised four new funds this year and has identified key areas of investment for both its proprietary portfolio and the private equity strategies it manages for clients. They are elderly care, medical care, semiconductors, consumption upgrading and financial technology.

And it will be hoping to tap a new vein of capital. This year mainland insurers started investing in CEL’s PE funds, said chief executive Chen Shuang at the firm’s first-half results conference in Hong Kong on Wednesday.

Certainly insurers have been ramping up their allocation to the private...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222